Lung Cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. All cases have definite pathological types, and pathological specimens (including lung biopsy or biopsy specimens, sputum based cell detection, lymph node puncture or biopsy specimens, fiberoptic bronchoscopy biopsy or brush examination or lavage fluid based cell examination, etc.) must be obtained in Shanghai Pulmonary Hospital. 2. All patients are confirmed as NSCLC patients, and the pathological features are adenocarcinoma, squamous cell carcinoma, squamous adenocarcinoma, large cell carcinoma or not classified.
Exclusion criteria
Exclusion criteria: 1. Patients with a history of pulmonary surgery complicated with other lung diseases (including interstitial pneumonia, sarcoidosis, large-scale tuberculosis, etc.); 2. Patients without pulmonary measurable lesion evaluation; 3. Patients with severe COPD or FEV1 < 50% of the predicted value; 4. Patients with other serious diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of grade 2 or above radiation pneumonitis within one year after radiotherapy; | — |
Secondary
| Measure | Time frame |
|---|---|
| Efficiency;survival rate; | — |
Countries
China
Contacts
Shanghai Pulmonary Hospital Affiliated to Tongji University